e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Epidemiology of total serum IgE in a large clinical cohort of subjects with severe or difficult-to-treat asthma
L. Borish, C. M. Dolan, Y. Deniz, B. Zheng (Charlottesville, S. San Francisco, United States Of America)
Source:
Annual Congress 2002 - Asthma
Session:
Asthma
Session type:
Thematic Poster Session
Number:
3200
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Borish, C. M. Dolan, Y. Deniz, B. Zheng (Charlottesville, S. San Francisco, United States Of America). Epidemiology of total serum IgE in a large clinical cohort of subjects with severe or difficult-to-treat asthma. Eur Respir J 2002; 20: Suppl. 38, 3200
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Association of serum IgE level and phadiatop with asthma, rhinitis and smoking in an elderly population from PAQUID cohort
Source: Eur Respir J 2001; 18: Suppl. 33, 436s
Year: 2001
Epidemiology of serum IgE in children with allergic asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 373s
Year: 2001
Monitoring free serum IgE in severe asthma patients treated with omalizumab
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Effect of omalizumab on the risk of hospitalisation in patients with uncontrolled severe asthma in real-life. The PAX-LASER cohort
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010
Clinical characteristics and burden of illness in a cohort of severe asthma patients
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016
Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Characteristics of super-responders to anti IL-5 biologics in a nationwide Danish severe asthma cohort
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
Characteristics of asthma patients with frequent exacerbations – an observational study in Sweden
Source: International Congress 2017 – Primary care management of asthma and self-management of respiratory disease
Year: 2017
Characteristics and outcomes of chronic cough in individuals with asthma: a population-based study
Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers
Year: 2018
Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019
Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Radiologic assed rhinosinusitis, eosinophils and lung function in a population-based cohort of elderly, a comparison of subjects with and without asthma
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020
Omalizumab in severe allergic asthma associated with COPD: a multicentric cohort study
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021
A clinically observed variability in serum total IgE in patients being considered for omalizumab therapy
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016
Comparison of demographic, functional and inflammatory features between atopic and non atopic asthmatics. Retrospective study on a large cohort of patients.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Effect of tezepelumab on the proportion of exacerbation-free patients with severe, uncontrolled asthma in NAVIGATOR
Source: Virtual Congress 2021 – Clinical trials in airway diseases: novel treatments and new evidence
Year: 2021
The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma
Source: Eur Respir J 2003; 22: 470-477
Year: 2003
Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort
Source: Eur Respir J 2015; 46: 1308-1321
Year: 2015
Characteristics of children with asthma and blood eosinophilia: an observational study
Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Year: 2021
The prevalence of subtypes of type-2 inflammation in a real-life population of patients with difficult-to-control asthma
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept